Search Results - "HOLTHOFF, V"

Innovative healthcare strategies in geriatric psychiatry and psychotherapy by Holthoff, V

“…The development of efficacious treatment strategies in older adults with mental illnesses is necessary. The growing number of homebound patients and the…”
Get full text

Pharmacotherapy of depression in the elderly by Holthoff, V

“…Depression is a common condition in older people, affecting in its moderate or severe forms around 4 % of those living in the community. Depression has been…”
Get full text

Effect of standardized post-coercion review on subjective coercion: Results of a randomized-controlled trial by Wullschleger, A, Vandamme, A, Mielau, J, Stoll, L, Heinz, A, Bermpohl, F, Bechdolf, A, Stelzig, M, Hardt, O, Hauth, I, Holthoff-Detto, V, Mahler, L, Montag, C

“…Post-coercion review has been increasingly regarded as a useful intervention in psychiatric inpatient setting. However, little is known about its effect on…”
Get full text

MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET by MOSCONI, L, PERANI, D, BORRONI, B, FRANCESCHI, M, BRACCO, L, PUPI, A, SORBI, S, HERHOLZ, K, NACMIAS, B, HOLTHOFF, V, SALMON, E, BARON, J.-C, DE CRISTOFARO, M. T. R, PADOVANI, A

“…To investigate whether the combination of fluoro-2-deoxy-d-glucose (FDG) PET measures with the APOE genotype would improve prediction of the conversion from…”
Get full text

Changes in brain metabolism associated with remission in unipolar major depression by Holthoff, V. A., Beuthien-Baumann, B., Zündorf, G., Triemer, A., Lüdecke, S., Winiecki, P., Koch, R., Füchtner, F., Herholz, K.

“…Objective:  Functional brain correlates of remission in patients with major depressive disorder (MDD) are measured with positron emission tomography (PET) and…”
Get full text

Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET by Herholz, K., Salmon, E., Perani, D., Baron, J-C., Holthoff, V., Frölich, L., Schönknecht, P., Ito, K., Mielke, R., Kalbe, E., Zündorf, G., Delbeuck, X., Pelati, O., Anchisi, D., Fazio, F., Kerrouche, N., Desgranges, B., Eustache, F., Beuthien-Baumann, B., Menzel, C., Schröder, J., Kato, T., Arahata, Y., Henze, M., Heiss, W-D.

“…A new diagnostic indicator of FDG PET scan abnormality, based on age-adjusted t statistics and an automated voxel-based procedure, is presented and validated…”
Get full text

Does lithium reduce acute suicidal ideation and behavior? A protocol for a randomized, placebo-controlled multicenter trial of lithium plus Treatment As Usual (TAU) in patients with suicidal major depressive episode by Lewitzka, U, Jabs, B, Fülle, M, Holthoff, V, Juckel, G, Uhl, I, Kittel-Schneider, S, Reif, A, Reif-Leonhard, C, Gruber, O, Djawid, B, Goodday, S, Haussmann, R, Pfennig, A, Ritter, P, Conell, J, Severus, E, Bauer, M

“…Lithium has proven suicide preventing effects in the long-term treatment of patients with affective disorders. Clinical evidence from case reports indicate…”
Get full text

A comparison of unawareness in frontotemporal dementia and Alzheimer’s disease by Salmon, E, Perani, D, Collette, F, Feyers, D, Kalbe, E, Holthoff, V, Sorbi, S, Herholz, K

“…Background:Loss of insight is a core diagnostic feature of frontotemporal dementia (FTD) and anosognosia is frequently reported in Alzheimer’s disease…”
Get full text

Anosognosia in very mild Alzheimer's disease but not in mild cognitive impairment by Kalbe, E, Salmon, E, Perani, D, Holthoff, V, Sorbi, S, Elsner, A, Weisenbach, S, Brand, M, Lenz, O, Kessler, J, Luedecke, S, Ortelli, P, Herholz, K

“…To study awareness of cognitive dysfunction in patients with very mild Alzheimer's disease (AD) and subjects with mild cognitive impairment (MCI). A complaint…”
Get more information

Functional Imaging During Recognition of Personally Familiar Faces and Places in Alzheimer's Disease by DONIX, Markus, JURJANZ, Luisa, MEYER, Shirin, AMANATIDIS, Eva C, BAEUMLER, Damaris, HUEBNER, Thomas, POETTRICH, Katrin, SMOLKA, Michael N, HOLTHOFF, Vjera A

“…Alzheimer's disease (AD) patients show better everyday functioning in a familiar setting, but they have a reduced ability to access contextual details and…”
Get full text

Dementia quality of life instrument - construct and concurrent validity in patients with mild to moderate dementia by Voigt-Radloff, S., Leonhart, R., Schützwohl, M., Jurjanz, L., Reuster, T., Gerner, A., Marschner, K., van Nes, F., Graff, M., Vernooij-Dassen, M., Rikkert, M. O., Holthoff, V., Hüll, M.

“…Background and purpose:  To translate the Dementia quality of life instrument (DQoL) into German and assess its construct and concurrent validity in…”
Get full text

Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography by Koeppe, R A, Holthoff, V A, Frey, K A, Kilbourn, M R, Kuhl, D E

“…The in vivo kinetic behavior of [11C]flumazenil ([11C]FMZ), a non-subtype-specific central benzodiazepine antagonist, is characterized using compartmental…”
Get more information

Cerebral metabolic correlates of four dementia scales in Alzheimer's disease by SALMON, E, LESPAGNARD, S, COLLETTE, F, GARRAUX, G, MARIQUE, P, PEETERS, F, HERHOLZ, K, PERANI, D, HOLTHOFF, V, KALBE, E, ANCHISI, D, ADAM, S

“…Different scales can be used to evaluate dementia severity in Alzheimer's disease (AD). They do assess different cognitive or functional abilities, but their…”
Get full text

Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits by Holthoff, V A, Vieregge, P, Kessler, J, Pietrzyk, U, Herholz, K, Bönner, J, Wagner, R, Wienhard, K, Pawlik, G, Heiss, W D

“…We evaluated 7 pairs of twins (2 monozygotic and 5 dizygotic) discordant for Parkinson's disease (PD), of whom the cotwins showed no signs of motor impairment…”
Get more information

Positron emission tomography demonstrates frontal cortex and basal ganglia hypometabolism in dystonia by KARBE, H, HOLTHOFF, V. A, RUDOLF, J, HERHOLZ, K, HEISS, W. D

“…We studied 15 dystonic patients with positron emission tomography (PET) and (18F)-2-fluoro-2-deoxy-D-glucose (FDG). The group comprised patients with focal (n…”
Get full text

Cerebral metabolic correlates of four dementia scales in Alzheimer’s disease by Salmon, E., Lespagnard, S., Marique, P., Peeters, F., Herholz, K., Perani, D., Holthoff, V., Kalbe, E., Anchisi, D., Adam, S., Collette, F., Garraux, G.

“…Different scales can be used to evaluate dementia severity in Alzheimer's disease (AD). They do assess different cognitive or functional abilities, but their…”
Get full text

MRI-Guided Flumazenil- and FDG-PET in Temporal Lobe Epilepsy by Szelies, B., Weber-Luxenburger, G., Pawlik, G., Kessler, J., Holthoff, V., Mielke, R., Herholz, K., Bauer, B., Wienhard, K., Heiss, W.-D.

“…In temporal lobe epilepsy (TLE) patients without lesions, major hippocampal sclerosis, or atrophy on magnetic resonance imaging (MRI), the localizing power of…”
Get full text

Innovative Versorgungsstrategien in der Gerontopsychiatrie und -psychotherapie by Holthoff, V.

“…Zusammenfassung Hintergrund Der demographische Wandel wird die gerontopsychiatrische Versorgung sowohl im Hinblick auf den Bedarf als auch hinsichtlich der…”
Get full text

In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment by Holthoff, V A, Herholz, K, Berthold, F, Widemann, B, Schröder, R, Neubauer, I, Heiss, W D

“…Despite an increasing interest in the clinical application of positron emission tomography (PET) in tumors of the adult patient as a diagnostic and prognostic…”
Get more information

Positron emission tomography measures of benzodiazepine receptors in Huntington's disease by Holthoff, V A, Koeppe, R A, Frey, K A, Penney, J B, Markel, D S, Kuhl, D E, Young, A B

“…We performed positron emission tomographic (PET) measurements of the regional distribution volume of benzodiazepine receptors and regional glucose metabolism…”
Get more information